| Q42284528 | A review of selected Arboviruses during pregnancy |
| Q39175768 | Antiviral activity of cationic amphiphilic drugs |
| Q92051257 | Climate Change, Health and Mosquito-Borne Diseases: Trends and Implications to the Pacific Region |
| Q43046989 | Congenital Zika syndrome and neuroimaging findings: what do we know so far? |
| Q38157349 | Could the Recent Zika Epidemic Have Been Predicted? |
| Q38156664 | Could the Use of Saliva Improve the Zika Diagnosis Challenge? Contributions from a Proteomics Perspective. |
| Q93058343 | Design, Synthesis, and Anti-RNA Virus Activity of 6'-Fluorinated-Aristeromycin Analogues |
| Q38157090 | Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future |
| Q90000423 | Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus |
| Q66679189 | Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus |
| Q51336228 | Imaging of congenital central nervous system infections. |
| Q51336052 | Infection by Zika viruses requires the transmembrane protein AXL, endocytosis and low pH. |
| Q56344333 | Infection-control knowledge, attitude, practice, and risk perception of occupational exposure to Zika virus among nursing students in Korea: A cross-sectional survey |
| Q30145524 | Is Zika Virus an Emerging TORCH Agent? An Invited Commentary |
| Q38157955 | Knowledge and attitudes towards Zika virus among medical students in King Abdulaziz University, Jeddah, Saudi Arabia |
| Q38156712 | Neurological Presentation of Zika Virus Infection Beyond the Perinatal Period. |
| Q92704609 | Participation of Extracellular Vesicles from Zika-Virus-Infected Mosquito Cells in the Modification of Naïve Cells' Behavior by Mediating Cell-to-Cell Transmission of Viral Elements |
| Q42347745 | Perspectives on the Zika outbreak: herd immunity, antibody-dependent enhancement and vaccine. |
| Q56000962 | Pregnant women co-infected with HIV and Zika: Outcomes and birth defects in infants according to maternal symptomatology |
| Q41673108 | Recent Perspectives on Genome, Transmission, Clinical Manifestation, Diagnosis, Therapeutic Strategies, Vaccine Developments, and Challenges of Zika Virus Research |
| Q55340881 | Selective constraint and adaptive potential of West Nile virus within and among naturally infected avian hosts and mosquito vectors. |
| Q64955468 | Sex-Specific Asymmetrical Attack Rates in Combined Sexual-Vectorial Transmission Epidemics. |
| Q29587277 | Spread of Zika virus in the Americas |
| Q60031635 | Tet-Inducible Production of Infectious Zika Virus from the Full-Length cDNA Clones of African- and Asian-Lineage Strains |
| Q61795461 | The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity |
| Q29224804 | Vaccines for Epidemic Infections and the Role of CEPI |
| Q84957990 | Vector competence of mosquitoes (Diptera: Culicidae) in Zika virus transmission: an integrative review |
| Q90088413 | Zika Virus: A Global Public Health Menace: A Comprehensive Update |
| Q51336553 | Zika virus and pregnancy in Brazil: What happened? |
| Q90115502 | Zika virus proteins at an atomic scale: how does structural biology help us to understand and develop vaccines and drugs against Zika virus infection? |